Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147

International Journal of Cancer

Volumn 139, Issue 5, 2016, Pages 986-995

  Phipps, Amanda I ^a,b   Shi, Qian ^c   Limburg, Paul J ^c   Nelson, Garth D ^c   Sargent, Daniel J ^c   Sinicrope, Frank A ^c   Chan, Emily ^d   Gill, Sharlene ^e   Goldberg, Richard M ^f   Kahlenberg, Morton ^g   Nair, Suresh ^h   Shields, Anthony F ⁱ   Newcomb, Polly A ^a,b   Alberts, Steven R ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c MAYO CLINIC   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f OHIO STATE UNIVERSITY   (United States)

^g Surgical Oncology Associates of South Texas   (United States)

^h LEHIGH VALLEY HOSPITAL   (United States)

ⁱ WAYNE STATE UNIVERSITY   (United States)

Author keywords

alcohol; colon cancer; recurrence; red wine; survival

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; DISEASE FREE SURVIVAL; DRINKING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; ADJUVANT CHEMOTHERAPY; COLONIC NEOPLASMS; FOLLOW UP; MIDDLE AGED; MORTALITY; PROGNOSIS; QUESTIONNAIRE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ANTINEOPLASTIC AGENT;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III AS TOPIC; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84966459998     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30135     Document Type: Article

References (44)

1. Phipps AI, Scoggins J, Rossing MA, et al., Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975-2007. Am J Public Health 2012; 102: 1791-7.
2. International Agency for Research on Cancer, World Health Organization. Alcohol consumption and ethyl carbamate. IARC monographs on the evaluation of carcinogenic risks to humans 2010. Volume 96. International Agency for Research on Cancer, Lyon, France.
3. Kune GA, Vitetta L., Alcohol consumption and the etiology of colorectal cancer: a review of the scientific evidence from 1957 to 1991. Nutr Cancer 1992; 18: 97-111.
4. Le Marchand L, Wilkens LR, Kolonel LN, et al., Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 1997; 57: 4787-94.
5. Longnecker MP, Orza MJ, Adams ME, et al., A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control 1990; 1: 59-68.
6. Mizoue T, Inoue M, Wakai K, et al., Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am J Epidemiol 2008; 167: 1397-406.
7. Moskal A, Norat T, Ferrari P, et al., Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer 2007; 120: 664-71.
8. Sharpe CR, Siemiatycki J, Rachet B., Effects of alcohol consumption on the risk of colorectal cancer among men by anatomical subsite (Canada). Cancer Causes Control 2002; 13: 483-91.
9. Maeda M, Nagawa H, Maeda T, et al., Alcohol consumption enhances liver metastasis in colorectal carcinoma patients. Cancer 1998; 83: 1483
10. Anton-Culver H., Smoking and other risk factors associated with the stage and age of diagnosis of colon and rectum cancers. Cancer Detect Prev 1991; 15: 345-50.
11. Phipps AI, Baron J, Newcomb PA., Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the seattle colon cancer family registry. Cancer 2011; 117: 4948-57.
12. Park SM, Lim MK, Shin SA, et al., Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: national health insurance corporation study. J Clin Oncol 2006; 24: 5017-24.
13. Pelser C, Arem H, Pfeiffer RM, et al., Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the national institutes of health (NIH)-AARP diet and health study. Cancer 2014; 120: 1540-7.
14. Patel SA, Chen YH, Hornick JL, et al., Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection. Dis Colon Rectum 2014; 57: 449-59.
15. Di Castelnuovo A, Costanzo S, Bagnardi V, et al., Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 2006; 166: 2437-45.
16. Alberts SR, Sargent DJ, Nair S, et al., Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA 2012; 307: 1383-93.
17. Domingo E, Laiho P, Ollikainen M, et al., BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 2004; 41: 664-8.
18. Lindor NM, Burgart LJ, Leontovich O, et al., Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20: 1043-8.
19. Kaplan EL, Meier P., Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
20. Hosmer DW, Jr, Lemeshow S., Applied survival analysis: regression modeling for time to event dated. New York: John Wiley & Sons, 1999.
21. Renaud S, de Lorgeril M., Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-6.
22. Hung LM, Chen JK, Huang SS, et al., Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 2000; 47: 549-55.
23. Mukamal KJ, Jensen MK, Gronbaek M, et al., Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 2005; 112: 1406-13.
24. Imhof A, Woodward M, Doering A, et al., Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J 2004; 25: 2092-100.
25. Blanco-Colio LM, Valderrama M, Alvarez-Sala LA, et al., Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation 2000; 102: 1020-6.
26. Chen Y, Tseng SH, Lai HS, et al., Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 2004; 136: 57-66.
27. Surh YJ, Hurh YJ, Kang JY, et al., Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett 1999; 140: 1-10.
28. Schneider Y, Duranton B, Gosse F, et al., Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 2001; 39: 102-7.
29. Zhou HB, Chen JJ, Wang WX, et al., Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 2005; 11: 280-4.
30. Wu SL, Sun ZJ, Yu L, et al., Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J Gastroenterol 2004; 10: 3048-52.
31. Signorelli P, Fabiani C, Brizzolari A, et al., Natural grape extracts regulate colon cancer cells malignancy. Nutr Cancer 2015; 67: 494-503.
32. Angel-Morales G, Noratto G, Mertens-Talcott S., Red wine polyphenolics reduce the expression of inflammation markers in human colon-derived CCD-18Co myofibroblast cells: potential role of microRNA-126. Food Funct 2012; 3: 745-52.
33. Mazue F, Delmas D, Murillo G, et al., Differential protective effects of red wine polyphenol extracts (RWEs) on colon carcinogenesis. Food Funct 2014; 5: 663-70.
34. Kwan ML, Kushi LH, Weltzien E, et al., Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol 2010; 28: 4410-6.
35. Han X, Zheng T, Foss FM, et al., Alcohol consumption and non-Hodgkin lymphoma survival. J Cancer Surviv 2010; 4: 101-9.
36. Zell JA, McEligot AJ, Ziogas A, et al., Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer 2007; 59: 36-45.
37. Slattery ML, Pellatt DF, Mullany LE, et al., Differential gene expression in colon tissue associated with diet, lifestyle, and related oxidative stress. PLoS One 2015; 10: e0134406
38. Fedirko V, Tramacere I, Bagnardi V, et al., Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 2011; 22: 1958-72.
39. Diergaarde B, Braam H, van Muijen GN, et al., Dietary factors and microsatellite instability in sporadic colon carcinomas. Cancer Epidemiol Biomarkers Prev 2003; 12: 1130-6.
40. Slattery ML, Curtin K, Anderson K, et al., Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000; 92: 1831-6.
41. Razzak AA, Oxentenko AS, Vierkant RA, et al., Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older women. Cancer Prev Res (Phila) 2011; 4: 2035-43.
42. Bongaerts BW, de Goeij AF, de Vogel S, et al., Alcohol consumption and distinct molecular pathways to colorectal cancer. Br J Nutr 2007; 97: 430-4.
43. Slattery ML, Anderson K, Curtin K, et al., Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 2001; 483: 73-81.
44. Slattery ML, Curtin K, Sweeney C, et al., Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer 2007; 120: 656-63.